Bisphosphonates in Clinical Oncology

The Development of Pamidronate

  • Beat Thürlimann

Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 149)

Table of contents

  1. Front Matter
    Pages I-XIV
  2. Beat Thürlimann
    Pages 1-20
  3. Beat Thürlimann
    Pages 21-57
  4. Beat Thürlimann
    Pages 59-106
  5. Beat Thürlimann
    Pages 107-113

About this book


This book provides a clinically oriented overview on the patho-physiological background and the use of bisphosphonates in oncology. The clinical development of pamidronate to treat tumor-induced hypercalcemia and malignant osteolytic bone disease is demonstrated, as well as the results of pivotal studies. New important findings on how to best use pamidronate in certain indications are given and put in perspective. The author discusses patient management guidelines as well as pharmaco-economic aspects important for the readers.


Metastatic Bone Disease Palliation Pamidronate Vitamin D bisphosphonates breast cancer hormones interferon metastasis necrosis pain pathogenesis pathophysiology physiology tumor

Authors and affiliations

  • Beat Thürlimann
    • 1
  1. 1.Abteilung für Onkologie und HämatologieKlinik C für Innere MedizinSt. GallenSwitzerland

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag Berlin Heidelberg 1999
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-64148-0
  • Online ISBN 978-3-642-59845-6
  • Series Print ISSN 0080-0015
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Oncology & Hematology